Metabolic implications of menopause

Seminars in Reproductive Medicine

Volumn 28, Issue 5, 2010, Pages 426-434

  Polotsky, Hanah N ^a   Polotsky, Alex J ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

cardiovascular risk; Menopause; metabolic syndrome; obesity

Indexed keywords

ADIPOCYTOKINE; GLUCOSE;

AGING; BLOOD PRESSURE; BODY FAT DISTRIBUTION; CARDIOVASCULAR RISK; CLIMACTERIUM; ENERGY EXPENDITURE; FEMALE GENITAL SYSTEM; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; MENOPAUSE; METABOLIC SYNDROME X; OBESITY; PHENOTYPE; REVIEW; RISK ASSESSMENT; WAIST CIRCUMFERENCE; WEIGHT CHANGE;

ABDOMINAL FAT; BIOLOGICAL MARKERS; BODY FAT DISTRIBUTION; CARDIOVASCULAR DISEASES; CHOLESTEROL; DIABETES MELLITUS; ENERGY INTAKE; ENERGY METABOLISM; EXERCISE; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; LIPIDS; MALE; MENOPAUSE; METABOLIC SYNDROME X; OBESITY; PERIMENOPAUSE; POSTMENOPAUSE; PREMENOPAUSE; PREVALENCE; RISK FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE; WEIGHT GAIN;

EID: 77957259658     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0030-1262902     Document Type: Review

References (78)

1. Abdel-Halim R E. Obesity: 1000 years ago. Lancet 2005 366 (9481) 204
2. Matthews K A., Meilahn E, Kuller L H., Kelsey S F., Caggiula A W., Wing R R. Menopause and risk factors for coronary heart disease. N Engl J Med 1989 321 (10) 641-646
3. Gordon T, Kannel W B., Hjortland M C., McNamara P M. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 1978 89 (2) 157-161
4. Lerner D J., Kannel W B. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986 111 (2) 383-390
5. Kannel W B., Levy D. Menopause, hormones, and cardiovascular vulnerability in women. Arch Intern Med 2004 164 (5) 479-481
6. Guthrie J R., Taffe J R., Lehert P, Burger H G., Dennerstein L. Association between hormonal changes at menopause and the risk of a coronary event: a longitudinal study. Menopause 2004 11 (3) 315-322
7. Matthews K A., Santoro N, Lasley B et al. Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases. J Clin Endocrinol Metab 2006 91 (5) 1789-1795
8. Janssen I, Powell L H., Crawford S, Lasley B, Sutton-Tyrrell K. Menopause and the metabolic syndrome: the Study of Women's Health across the Nation. Arch Intern Med 2008 168 (14) 1568-1575
9. Janssen I. Influence of age on the relation between waist circumference and cardiometabolic risk markers. Nutr Metab Cardiovasc Dis 2009 19 (3) 163-169
10. Pasquali R, Casimirri F, Labate A M. et al, The VMH Collaborative Group. Body weight, fat distribution and the menopausal status in women. Int J Obes Relat Metab Disord 1994 18 (9) 614-621
11. Matthews K A., Abrams B, Crawford S et al. Body mass index in mid-life women: relative influence of menopause, hormone use, and ethnicity. Int J Obes Relat Metab Disord 2001 25 (6) 863-873
12. Derby C A., Crawford S L., Pasternak R C., Sowers M, Sternfeld B, Matthews K A. Lipid changes during the menopause transition in relation to age and weight: the Study of Women's Health across the Nation. Am J Epidemiol 2009 169 (11) 1352-1361
13. Wing R R., Matthews K A., Kuller L H., Meilahn E N., Plantinga P L. Weight gain at the time of menopause. Arch Intern Med 1991 151 (1) 97-102
14. Sherman B M., West J H., Korenman S G. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab 1976 42 (4) 629-636
15. Weinberg M E., Manson J E., Buring J E. et al. Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women. Metabolism 2006 55 (11) 1473-1480
16. Chahal H S., Drake W M. The endocrine system and ageing. J Pathol 2007 211 (2) 173-180
17. Soules M R., Sherman S, Parrott E et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 2001 76 (5) 874-878 (Pubitemid 33031310)
18. Ogden C L., Carroll M D., Curtin L R., McDowell M A., Tabak C J., Flegal K M. Prevalence of overweight and obesity in the United States, 19992004. JAMA 2006 295 (13) 1549-1555
19. Espeland M A., Stefanick M L., Kritz-Silverstein D et al, Postmenopausal Estrogen-Progestin Interventions Study Investigators. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. J Clin Endocrinol Metab 1997 82 (5) 1549-1556
20. Kritz-Silverstein D, Barrett-Connor E. Long-term postmenopausal hormone use, obesity, and fat distribution in older women. JAMA 1996 275 (1) 46-49
21. Sternfeld B, Wang H, Quesenberry C P. Jr et al. Physical activity and changes in weight and waist circumference in midlife women: findings from the Study of Women's Health across the Nation. Am J Epidemiol 2004 160 (9) 912-922
22. Macdonald H M., New S A., Campbell M K., Reid D M. Longitudinal changes in weight in perimenopausal and early postmenopausal women: effects of dietary energy intake, energy expenditure, dietary calcium intake and hormone replacement therapy. Int J Obes Relat Metab Disord 2003 27 (6) 669-676
23. Lovejoy J C., Champagne C M., de Jonge L, Xie H, Smith S R. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond) 2008 32 (6) 949-958
24. Lovejoy J C. Weight gain in women at midlife: the influence of menopause. Obesity Management 2009 5 52-56
25. Polotsky A J., Santoro N. Menopause and cardiovascular disease: endogenous reproductive hormone exposure affects risk factors. Menopause Manage 2007 16 (2) 21-25
26. Shimokata H, Andres R, Coon P J., Elahi D, Muller D C., Tobin J D. Studies in the distribution of body fat. II. Longitudinal effects of change in weight. Int J Obes 1989 13 (4) 455-464
27. Ley C J., Lees B, Stevenson J C. Sex- and menopause-associated changes in body-fat distribution. Am J Clin Nutr 1992 55 (5) 950-954
28. Franklin R M., Ploutz-Snyder L, Kanaley J A. Longitudinal changes in abdominal fat distribution with menopause. Metabolism 2009 58 (3) 311-315
29. Berg A H., Scherer P E. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005 96 (9) 939-949
30. Winzer C, Wagner O, Festa A et al. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 2004 27 (7) 1721-1727
31. Gustafson B, Hammarstedt A, Andersson C X., Smith U. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 2007 27 (11) 2276-2283
32. Lee C G., Carr M C., Murdoch S J. et al. Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J Clin Endocrinol Metab 2009 94 (4) 1104-1110
33. Grundy S M. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007 92 (2) 399-404
34. Kahn R, Buse J, Ferrannini E, Stern M, American Diabetes Association European Association for the Study of Diabetes. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005 28 (9) 2289-2304 (Pubitemid 41242486)
35. Nilsson P M. Cardiovascular risk in the metabolic syndrome: fact or fiction? Curr Cardiol Rep 2007 9 (6) 479-485
36. Alberti K GMMF, Eckel R HMDF, Grundy S MMDPF et al, International Diabetes Federation Task Force on Epidemiology and Prevention Hational Heart, Lung, and Blood Institute American Heart Association World Heart Federation International Atherosclerosis Society International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009 120 (16) 1640-1645
37. Ford E S., Giles W H., Mokdad A H. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004 27 (10) 2444-2449
38. Bauersachs R, Lindhoff-Last E. Anticoagulation of pregnant women with mechanical heart valves using low-molecular-weight heparin. Arch Intern Med 2003 163 (22) 2788-2789
39. Carr M C. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003 88 (6) 2404-2411
40. Frayn K N. Visceral fat and insulin resistancecausative or correlative? Br J Nutr 2000 83 (Suppl 1) S71-S77
41. Weinberg M E., Manson J E., Buring J E. et al. Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women. Metabolism 2006 55 (11) 1473-1480
42. Janssen I, Powell L H., Crawford S, Lasley B, Sutton-Tyrrell K. Menopause and the metabolic syndrome: the Study of Women's Health across the Nation. Arch Intern Med 2008 168 (14) 1568-1575
43. Torrns J I., Sutton-Tyrrell K, Zhao X et al. Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women: study of Women's Health across the Nation. Menopause 2009 16 (2) 257-264
44. Mokdad A H., Ford E S., Bowman B A. et al. Diabetes trends in the U.S.: 19901998. Diabetes Care 2000 23 (9) 1278-1283
45. Department of Health ad Human Services Centers for Disease Control and Prevention. National diabetes fact sheet 2007. Available at: http://www.cdc.gov/diabetes/pubs/factsheet07.htm Accessed July 22, 2010
46. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009 32 (Suppl 1) 62-67
47. Sites C K., Calles-Escandn J, Brochu M, Butterfield M, Ashikaga T, Poehlman E T. Relation of regional fat distribution to insulin sensitivity in postmenopausal women. Fertil Steril 2000 73 (1) 61-65
48. Campbell A J., Busby W J., Horwath C C., Robertson M C. Relation of age, exercise, anthropometric measurements, and diet with glucose and insulin levels in a population aged 70 years and over. Am J Epidemiol 1993 138 (9) 688-696
49. Szmuilowicz E D., Stuenkel C A., Seely E W. Influence of menopause on diabetes and diabetes risk. Nat Rev Endocrinol 2009 5 (10) 553-558
50. Muscelli E, Kozkov M, Flyvbjerg A et al, RISC investigators. The effect of menopause on carotid artery remodeling, insulin sensitivity, and plasma adiponectin in healthy women. Am J Hypertens 2009 22 (4) 364-370
51. Soriguer F, Morcillo S, Hernando V et al. Type 2 diabetes mellitus and other cardiovascular risk factors are no more common during menopause: longitudinal study. Menopause 2009 16 (4) 817-821
52. Dorman J S., Steenkiste A R., Foley T P. et al, Familial Autoimmune and Diabetes (FAD) Study. Menopause in type 1 diabetic women: is it premature? Diabetes 2001 50 (8) 1857-1862
53. Malacara J M., Huerta R, Rivera B, Esparza S, Fajardo M E. Menopause in normal and uncomplicated NIDDM women: physical and emotional symptoms and hormone profile. Maturitas 1997 28 (1) 35-45
54. Lpez-Lpez R, Huerta R, Malacara J M. Age at menopause in women with type 2 diabetes mellitus. Menopause 1999 6 (2) 174-178
55. Verhaeghe J. Menopause care for obese and diabetic women. Facts Views Vision Obgyn 2009 1 (2) 142-152
56. Korytkowski M T., Krug E I., Daly M A., Deriso L, Wilson J W., Winters S J. Does androgen excess contribute to the cardiovascular risk profile in postmenopausal women with type 2 diabetes? Metabolism 2005 54 (12) 1626-1631
57. Wajchenberg B L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000 21 (6) 697-738
58. Middelberg R P., Spector T D., Swaminathan R, Snieder H. Genetic and environmental influences on lipids, lipoproteins, and apolipoproteins: effects of menopause. Arterioscler Thromb Vasc Biol 2002 22 (7) 1142-1147
59. Mackey R H., Kuller L H., Sutton-Tyrrell K, Evans R W., Holubkov R, Matthews K A. Lipoprotein subclasses and coronary artery calcium in postmenopausal women from the healthy women study. Am J Cardiol 2002 90 (8A, 8A) 71i-76i
60. Hokanson J E., Austin M A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996 3 (2) 213-219
61. Coylewright M, Reckelhoff J F., Ouyang P. Menopause and hypertension: an age-old debate. Hypertension 2008 51 (4) 952-959
62. Stampfer M J., Colditz G A., Willett W C. Menopause and heart disease. A review. Ann N Y Acad Sci 1990 592 193-203, discussion 257262
63. Izumi Y, Matsumoto K, Ozawa Y et al. Effect of age at menopause on blood pressure in postmenopausal women. Am J Hypertens 2007 20 (10) 1045-1050
64. Barton M, Meyer M R. Postmenopausal hypertension: mechanisms and therapy. Hypertension 2009 54 (1) 11-18
65. Kannel W B. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am Heart J 1987 114 (2) 413-419
66. Schillaci G, Verdecchia P, Borgioni C, Ciucci A, Porcellati C. Early cardiac changes after menopause. Hypertension 1998 32 (4) 764-769
67. Byington R P., Davis B R., Plehn J F. et al. Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project. Circulation 2001 103 (3) 387-392
68. Collins P, Rosano G, Casey C et al. Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists. Eur Heart J 2007 28 (16) 2028-2040 (Pubitemid 47579557)
69. Guthrie J R., Taffe J R., Lehert P, Burger H G., Dennerstein L. Association between hormonal changes at menopause and the risk of a coronary event: a longitudinal study. Menopause 2004 11 (3) 315-322
70. Kannel W B., Dawber T R., Kagan A, Revotskie N, Stokes J III. Factors of risk in the development of coronary heart diseasesix year follow-up experience. The Framingham Study. Ann Intern Med 1961 55 33-50
71. Khot U N., Khot M B., Bajzer C T. et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003 290 (7) 898-904
72. Ridker P M., Buring J E., Rifai N, Cook N R. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007 297 (6) 611-619
73. Cuff D J., Meneilly G S., Martin A, Ignaszewski A, Tildesley H D., Frohlich J J. Effective exercise modality to reduce insulin resistance in women with type 2 diabetes. Diabetes Care 2003 26 (11) 2977-2982
74. Bergström I, Lombardo C, Brinck J. Physical training decreases waist circumference in postmenopausal borderline overweight women. Acta Obstet Gynecol Scand 2009 88 (3) 308-313
75. Kuller L H., Simkin-Silverman L R., Wing R R., Meilahn E N., Ives D G. Women's Healthy Lifestyle Project: a randomized clinical trial: results at 54 months. Circulation 2001 103 (1) 32-37
76. Simkin-Silverman L R., Wing R R., Boraz M A., Kuller L H. Lifestyle intervention can prevent weight gain during menopause: results from a 5-year randomized clinical trial. Ann Behav Med 2003 26 (3) 212-220
77. Knowler W C., Barrett-Connor E, Fowler S E. et al, Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002 346 (6) 393-403
78. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adultsthe evidence report. Obes Res 1998 6 (Suppl 2) 51S-209S